Skip to end of metadata
Go to start of metadata
- adherence, patient compliance
- ADME (absorption, distribution, metabolism, excretion)
- arms race
- bioaccumulation
- biosecurity
- bottleneck — population bottleneck, genetic bottleneck
- bully pulpit
- carrier, asymptomatic carrier
- Central Dogma
- chirality
- clinical endpoint, clinical outcome
- coevolution
- coinfection
- community and patient participation
- contamination
- cure vs. remission of HIV/AIDS
- disease surveillance
- dose response
- drug discovery and development
- drug resistance
- drug safety
- endangered species
- endogenous retrovirus (ERV)
- generic drug
- habituation
- HIV vaccine
- homophobia
- IC50 (half maximal inhibitory concentration)
- iceberg of disease
- incubation period
- information, genetic
- in vitro vs. in vivo
- mechanism
- microbiota, microbiome
- molecular clock
- natural selection, evolutionary selection, evolutionary fitness
- non-maleficence (primum non nocere)
- nucleic acid hybridization
- observation
- oncovirus
- phylogenetics
- pre-exposure prophylaxis (PrEP)
- prevention of HIV/AIDS
- prodrug
- provirus
- retrovirus classification, subfamilies, and genera
- RNA splicing
- sensitivity and specificity; false positive, false negative; biological specificity
- sex, sexually transmitted infection (STI)
- spillover, zoonotic disease, xenotropic virus
- structural biology
- surrogate marker (surrogate endpoint)
- transactivation
- transcriptome
- treatment-as-prevention (TasP)
- tropical disease, tropical medicine
- tropism
- vectored immunoprophylaxis (VIP)
- viral load
- viral reservoir, viral latency, disease reservoir
- viremia
{"serverDuration": 88, "requestCorrelationId": "edc2fa354181d8ae"}